Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    " January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
2 Active, not recruiting
Has Results
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: E/C/F/TDF Placebo;   Drug: E/C/F/TAF Placebo
3 Unknown  Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
4 Completed Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
5 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
6 Active, not recruiting Living Well Project for Persons With AIDS
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
7 Completed Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
8 Active, not recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
9 Completed An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
10 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
11 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
12 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: AIDS-Related Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Stage IIA Hodgkin Lymphoma;   Stage IIB Hodgkin Lymphoma;   Stage IIIA Hodgkin Lymphoma;   Stage IIIB Hodgkin Lymphoma;   Stage IVA Hodgkin Lymphoma;   Stage IVB Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Drug: Dacarbazine;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Vinblastine
13 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
14 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
15 Completed Switching Undetectables to Selzentry
Conditions: Human Immunodeficiency Virus;   AIDS
Intervention: Drug: Maraviroc
16 Recruiting Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Suubi+Adherence;   Behavioral: Bolstered Standard of Care
17 Active, not recruiting Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Chronic Obstructive Pulmonary Disease;   HIV
Intervention:
18 Completed The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Behavioral: Multimedia WORTH;   Behavioral: Traditional WORTH;   Behavioral: Wellness Promotion
19 Recruiting Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
Conditions: HIV;   AIDS;   Substance Abuse
Interventions: Behavioral: Enhanced HIV Care Access and Retention Intervention;   Behavioral: HIV Testing Campaign;   Behavioral: Treatment Re-engagement Campaign;   Behavioral: Patient Navigator Linkage to Care and Substance Abuse Treatment Team;   Behavioral: Mobile Care Clinic
20 Completed Home-based Partner Education and Testing (HOPE) Study
Condition: HIV
Interventions: Behavioral: HOPE Intervention;   Behavioral: INVITE Intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years